Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study

Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study

Objectives We aimed to evaluate the risk of colorectal adenocarcinoma (CRA) associated with long-term use of proton pump inhibitors (PPIs) in a large nationwide cohort.Design Retrospective cohort study.Setting This research was conducted at the national level, encompassing the entire population of S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lars Engstrand, Nele Brusselaers, Qing Liu, Katja Fall, Omid Sadr-Azodi, Xinchen Wang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-07-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/14/7/e079591.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proton pump inhibitors and all-cause mortality in colorectal cancer
by: Arunkumar Krishnan, et al.
Published: (2025-07-01)

Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01)

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
by: Teppei Okamoto, et al.
Published: (2018-01-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)

Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023-11-01)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)

Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population‐based cohort study
by: Unnur Gudnadottir, et al.
Published: (2024-08-01)

Six stabs in the back of proton pump inhibitors
by: Andrei Evgenyevich Karateev
Published: (2013-06-01)

Proton Pump Inhibitors in the COVID-19 Pandemic
by: T. E. Kugler, et al.
Published: (2022-08-01)

Is a proton pump inhibitor (PPI) the GP's gastroscopy?
by: H.R. Schneider
Published: (2005-03-01)

Can Proton Pump Inhibitors Affect Eradication Therapy?
by: Sung Eun Kim
Published: (2020-09-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

Proton Pump Inhibitor Long-term Prescription, Is It Safe?
by: Tae Ho Kim
Published: (2020-06-01)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
by: Sung Soo Kim, et al.
Published: (2017-06-01)

Hip Fracture and Proton Pump Inhibitor Therapy: Position Statement
by: Paul Moayyedi
Published: (2008-01-01)

Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women
by: Ahmed I. Soliman, et al.
Published: (2025-07-01)

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS
by: Yu. V. Muravyev, et al.
Published: (2018-11-01)

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
by: Maxwell Rossip, et al.
Published: (2025-06-01)

Alarming Trends in Proton Pump Inhibitor (PPI) Misuse in Bangladesh
by: Md Nasir Ahmed, et al.
Published: (2025-06-01)

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS?
by: Andrey E Karateev, et al.
Published: (2014-02-01)

Proton Pump Inhibitor Omeprazole Alters the Spiking Characteristics of Proteinoids
by: Panagiotis Mougkogiannis, et al.
Published: (2025-01-01)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
by: Simone Janett, et al.
Published: (2015-01-01)

Acute Kidney Injury After the Concurrent Use of Checkpoint Inhibitors and Proton Pump Inhibitors
by: Helen I. Gandler, et al.
Published: (2024-02-01)

Current Physician's Perception of Proton Pump Inhibitor-related Adverse Effects
by: Cheol Woong Choi
Published: (2021-03-01)

Current management of proton pump inhibitor-refractory gastroesophageal reflux disease
by: V. V. Tsukanov, et al.
Published: (2020-06-01)

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)

By correcting hyperhomocysteinemia and background in dyslipidemia of prolonged use of proton pump inhibitors
by: A. V. Zharkova
Published: (2013-02-01)

Proton pump inhibitor therapy in a child with chemotherapy induced pancreatitis
by: Nese Yarali, et al.
Published: (2014-08-01)

The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors
by: Raquel Vázquez-Mourelle, et al.
Published: (2017-01-01)

Cost-Effectiveness of Intravenous Proton Pump Inhibitors in High-Risk Bleeders
by: Sander Veldhuyzen van Zanten
Published: (2004-01-01)

Ilaprazole: Distinctive pharmacokinetic and pharmacodynamic properties among proton pump inhibitors
by: Hubert Igno Castus, et al.
Published: (2025-07-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
by: Tae Jun Kim, et al.
Published: (2020-09-01)

IMMEDIATE AND DELAYED HYPERSENSITIVITY REACTIONS TO PROTON PUMP INHIBITORS: A REVIEW ARTICLE
by: Corovic Vahida, et al.
Published: (2025-05-01)

Effects of Proton Pump Inhibitors and H2 Receptor Antagonists on the Ileum Motility
by: Atilla Kurt, et al.
Published: (2011-01-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
by: Mizue Tanaka, et al.
Published: (2014-01-01)

Evaluation of the effect of proton pump inhibitors on swallowing impairment symptoms after thyroidectomy
by: Heba Elsayed Elghazouly, et al.
Published: (2025-08-01)

In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles
by: Ádám Kerek, et al.
Published: (2025-07-01)